Carregant...
Novel treatments for immune thrombocytopenia
Primary immune thrombocytopenia (ITP) is caused by platelet autoantibodies and T-cell dysregulation. Both platelets and their precursor megakaryocytes may be targeted leading to platelet destruction and underproduction. Current treatments for ITP are inadequate since they do not reverse the disease...
Guardat en:
| Publicat a: | Presse Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4880474/ https://ncbi.nlm.nih.gov/pubmed/24656294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lpm.2014.02.006 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|